🏥 治験ポータル
← 治験一覧に戻る

再発性虚血性脳卒中の予防のための疾患管理プログラムの効果

基本情報

NCT ID
NCT02121327
ステータス
完了
試験のフェーズ
該当なし
試験タイプ
介入
目標被験者数
321
治験依頼者名
Hiroshima University

概要

It has been reported that stroke is the first cause of becoming bedridden, and its cumulative recurrence rate in 5 years is approximately 35%. There is a high probability that patients reduce or discontinue medications by self-determination, leading to a high risk of stroke recurrence in these patients. Comprehensive and long-term patient educations ameliorating their self-management are important making patients possible to be managed according to the guidelines for their risk factors. Using disease management programs created for each of risk factors according to clinical practice guidelines, the influence of those programs were evaluated for the prevention of stroke recurrence in this Disease Management Program Stroke Trial.

対象疾患

Ischemic Stroke

介入

disease management(OTHER)
usual care(OTHER)

実施施設 (1)

広島大学病院

Hiroshima, Hiroshima, Japan